HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Busiku Hamainza Selected Research

piperaquine

1/2022Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data.
1/2020Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin-Piperaquine Implemented in Southern Province, Zambia.
1/2020Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin-Piperaquine in Southern Province, Zambia.
1/2020Cost-Effectiveness of Focal Mass Drug Administration and Mass Drug Administration with Dihydroartemisinin-Piperaquine for Malaria Prevention in Southern Province, Zambia: Results of a Community-Randomized Controlled Trial.
11/2017Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia.
12/2016Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.
8/2015Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Busiku Hamainza Research Topics

Disease

53Malaria
05/2024 - 03/2009
16Infections
03/2023 - 03/2009
5Falciparum Malaria (Plasmodium falciparum Malaria)
02/2024 - 11/2014
5Fever (Fevers)
10/2013 - 03/2009
2Parasitic Diseases (Parasitic Disease)
08/2015 - 01/2011
2Pneumonia (Pneumonitis)
11/2012 - 09/2010
1COVID-19
11/2022
1Reinfection
11/2014
1Anemia
01/2011

Drug/Important Bio-Agent (IBA)

15Antimalarials (Antimalarial Agents)IBA
02/2024 - 03/2009
10InsecticidesIBA
05/2024 - 03/2009
8Indicators and Reagents (Reagents)IBA
11/2023 - 09/2012
7Lumefantrine Drug Combination Artemether (Coartem)FDA Link
03/2023 - 09/2010
7piperaquineIBA
01/2022 - 08/2015
7artenimol (dihydroartemisinin)IBA
01/2022 - 08/2015
7artemisinin (artemisinine)IBA
07/2021 - 03/2009
4Pyrethrins (Pyrethroids)FDA Link
08/2020 - 12/2012
3insulin receptor-related receptor (IRR)IBA
03/2023 - 01/2014
3pirimiphos methyl (Aktel)IBA
04/2021 - 02/2016
33-O-(methylthiomethyl)apiitol tetraacetateIBA
05/2015 - 04/2015
2VaccinesIBA
02/2024 - 11/2022
2Complement System Proteins (Complement)IBA
01/2020 - 08/2015
2Amoxicillin (Wymox)FDA LinkGeneric
11/2012 - 09/2010
1SugarsIBA
05/2024
1A 19IBA
03/2023
1EnzymesIBA
03/2023
1ImmunosorbentsIBA
03/2023
1pyrimethamine drug combination fanasil (Fansidar)FDA Link
01/2023
1Chloroquine (Aralen)FDA LinkGeneric
07/2021
1AntigensIBA
04/2019
1Azure Stains (Giemsa Stain)IBA
04/2019
1PolyestersIBA
04/2018
1OrganophosphatesIBA
02/2016
1decamethrin (deltamethrin)IBA
02/2016
1cyhalothrinIBA
02/2016
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
11/2014
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
01/2014
1DDTIBA
12/2012
1Anti-Bacterial Agents (Antibiotics)IBA
09/2010

Therapy/Procedure

12Mass Drug Administration
01/2022 - 05/2015
7Therapeutics
12/2014 - 03/2009
3Insecticide-Treated Bednets
03/2016 - 01/2011
1Chemoprevention
12/2021
1Mosquito Nets
01/2021